W. Brigden, Uncommon myocardial diseases: the non-coronary cardiomyopathies, Lancet, vol.273, pp.1243-1252, 1957.

M. Codd, D. Sugrue, B. Gersh, and L. Melton, Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, Circulation, vol.80, pp.1975-1984564, 1989.

P. Elliott and W. Mckenna, Hypertrophic cardiomyopathy, The Lancet, vol.363, issue.9424, pp.1881-91, 2004.
DOI : 10.1016/S0140-6736(04)16358-7

B. Maron, Hypertrophic Cardiomyopathy, JAMA, vol.287, issue.10, pp.1308-1328, 2002.
DOI : 10.1001/jama.287.10.1308

P. Charron and M. Komajda, Cardiomyopathies hypertrophiques, Arch Mal Coeur Vaiss, vol.96, pp.1042-1049, 2003.

B. Maron, W. Mckenna, and G. Danielson, American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines, European Heart Journal, vol.24, issue.21, pp.1687-713, 2003.
DOI : 10.1016/S0195-668X(03)00479-2

P. Charron, G??n??tique des cardiomyopathies hypertrophiques, Archives de P??diatrie, vol.10, issue.1, pp.80-82, 2003.
DOI : 10.1016/S0929-693X(03)90391-5

P. Elliott, G. Blanes, J. Mahon, N. Poloniecki, J. Mckenna et al., Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy, The Lancet, vol.357, issue.9254, pp.420-424, 2001.
DOI : 10.1016/S0140-6736(00)04005-8

S. Maki, H. Ikeda, and A. Muro, Predictors of sudden cardiac death in hypertrophic cardiomyopathy, The American Journal of Cardiology, vol.82, issue.6, pp.774-782, 1998.
DOI : 10.1016/S0002-9149(98)00455-X

B. Maron, D. Savage, J. Wolfson, and S. Epstein, Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study, The American Journal of Cardiology, vol.48, issue.2, pp.252-259, 1981.
DOI : 10.1016/0002-9149(81)90604-4

L. Monserrat, P. Elliott, J. Gimeno, S. Sharma, M. Penas-lado et al., Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients, ACC Current Journal Review, vol.13, issue.1, pp.873-882, 2003.
DOI : 10.1016/j.accreview.2003.10.024

N. Sadoul, K. Prasad, P. Elliott, S. Bannerjee, M. Frenneaux et al., Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy, Circulation, vol.96, issue.9, pp.2987-91, 1997.
DOI : 10.1161/01.CIR.96.9.2987

R. Kim, D. Shah, and R. Judd, How We Perform Delayed Enhancement Imaging, Journal of Cardiovascular Magnetic Resonance, vol.5, issue.3, pp.505-519, 2003.
DOI : 10.1081/JCMR-120022267

URL : http://www.scmr.org/assets/files/members/documents/JCMR_DEMRI.pdf

O. Hanlon, R. Grasso, A. Roughton, and M. , Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, vol.56, issue.11, pp.867-74
DOI : 10.1016/j.jacc.2010.05.010

T. Suk, C. Edwards, H. Hart, and J. Christiansen, Myocardial Scar Detected by Contrast-Enhanced Cardiac Magnetic Resonance Imaging is Associated with Ventricular Tachycardia in Hypertrophic Cardiomyopathy Patients, Heart, Lung and Circulation, vol.17, issue.5, pp.370-374, 2008.
DOI : 10.1016/j.hlc.2008.03.080

J. Langlard, Cardiomyopathies restrictives, Arch Mal Coeur Vaiss, vol.91, pp.59-64, 1998.
DOI : 10.1016/j.emcaa.2003.08.002

A. Torp, Incidence of congestive cardiomyopathy., Postgraduate Medical Journal, vol.54, issue.633, pp.435-444, 1978.
DOI : 10.1136/pgmj.54.633.435

R. Gillum, Idiopathic cardiomyopathy in the United States, 1970???1982, American Heart Journal, vol.111, issue.4, pp.752-757, 1986.
DOI : 10.1016/0002-8703(86)90111-0

D. Williams and E. Olsen, Prevalence of overt dilated cardiomyopathy in two regions of England., Heart, vol.54, issue.2, pp.153-158, 1985.
DOI : 10.1136/hrt.54.2.153

J. Bagger, U. Baandrup, K. Rasmussen, M. Moller, and T. Vesterlund, Cardiomyopathy in western Denmark., Heart, vol.52, issue.3, pp.327-358, 1984.
DOI : 10.1136/hrt.52.3.327

URL : http://europepmc.org/articles/pmc481633?pdf=render

R. Lang, M. Bierig, and R. Devereux, Recommendations for chamber quantification???, European Journal of Echocardiography, vol.7, issue.2, pp.79-108, 2006.
DOI : 10.1016/j.euje.2005.12.014

R. Johnson and I. Palacios, Dilated Cardiomyopathies of the Adult, New England Journal of Medicine, vol.307, issue.17, pp.1051-1059, 1982.
DOI : 10.1056/NEJM198210213071704

G. Dec and V. Fuster, Idiopathic Dilated Cardiomyopathy, New England Journal of Medicine, vol.331, issue.23, pp.1564-75, 1994.
DOI : 10.1056/NEJM199412083312307

V. Ferrans, Pathologic anatomy of the dilated cardiomyopathies, The American Journal of Cardiology, vol.64, issue.6, pp.9-11, 1989.
DOI : 10.1016/0002-9149(89)90677-2

V. Fuster, B. Gersh, E. Giuliani, A. Tajik, R. Brandenburg et al., The natural history of idiopathic dilated cardiomyopathy, The American Journal of Cardiology, vol.47, issue.3, pp.525-556, 1981.
DOI : 10.1016/0002-9149(81)90534-8

W. Follansbee, E. Michelson, and J. Morganroth, Nonsustained Ventricular Tachycardia in Ambulatory Patients: Characteristics and Association with Sudden Cardiac Death, Annals of Internal Medicine, vol.92, issue.6, pp.741-748, 1980.
DOI : 10.7326/0003-4819-92-6-741

R. Diaz, A. Obasohan, and C. Oakley, Prediction of outcome in dilated cardiomyopathy., Heart, vol.58, issue.4, pp.393-402, 1987.
DOI : 10.1136/hrt.58.4.393

M. Komajda, J. Jais, and F. Reeves, Factors predicting mortality in idiopathic dilated cardiomyopathy, European Heart Journal, vol.11, issue.9, pp.824-855, 1990.
DOI : 10.1093/oxfordjournals.eurheartj.a059803

D. Sugrue, R. Rodeheffer, M. Codd, D. Ballard, V. Fuster et al., The Clinical Course of Idiopathic Dilated Cardiomyopathy, Annals of Internal Medicine, vol.117, issue.2, pp.117-140, 1992.
DOI : 10.7326/0003-4819-117-2-117

S. Hunt, . Acc, and . Aha, ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult, Journal of the American College of Cardiology, vol.46, issue.6, pp.1-82, 2005.
DOI : 10.1016/j.jacc.2005.08.022

K. Dickstein, A. Cohen-solal, and G. Filippatos, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008???, European Journal of Heart Failure, vol.9, issue.4, pp.2388-442, 2008.
DOI : 10.1016/j.ejheart.2007.04.003

A. Cowley, J. Rowley, K. Stainer, and J. Hampton, Captopril therapy for heart failure. A placebo controlled study, Lancet, vol.2, pp.730-732, 1982.
DOI : 10.1016/s0140-6736(82)90920-5

F. Kleber, L. Niemoller, and W. Doering, Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial., Heart, vol.67, issue.4, pp.289-96, 1992.
DOI : 10.1136/hrt.67.4.289

R. Garg and S. Yusuf, Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials, JAMA: The Journal of the American Medical Association, vol.273, issue.18, pp.1450-1456, 1995.
DOI : 10.1001/jama.273.18.1450

A. Hjalmarson and F. Waagstein, New therapeutic strategies in chronic heart failure: challenge of long-term beta-blockade, European Heart Journal, vol.12, issue.suppl F, pp.63-72, 1991.
DOI : 10.1093/eurheartj/12.suppl_F.63

A. Segev, Y. Mekori, A. Hjalmarson, S. Goldstein, and B. Fagerberg, The Cardiac Insufficiency Bisoprolol Study II Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group, Lancet JAMA, vol.353283, pp.1361-401295, 1999.

F. Waagstein, M. Bristow, and K. Swedberg, Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy, The Lancet, vol.342, issue.8885, pp.1441-1447, 1993.
DOI : 10.1016/0140-6736(93)92930-R

M. Packer, M. Fowler, and E. Roecker, Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study, Circulation, vol.106, issue.17, pp.2194-2203, 2002.
DOI : 10.1161/01.CIR.0000035653.72855.BF

K. Dickstein, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides: reply, European Heart Journal, vol.10, issue.10, 2008.
DOI : 10.1093/eurheartj/ehn309

D. Brater, Diuretic Therapy, New England Journal of Medicine, vol.339, issue.6, pp.387-95, 1998.
DOI : 10.1056/NEJM199808063390607

R. Cody, S. Kubo, and K. Pickworth, Diuretic Treatment for the Sodium Retention of Congestive Heart Failure, Archives of Internal Medicine, vol.154, issue.17, pp.1905-1919, 1994.
DOI : 10.1001/archinte.1994.00420170045004

B. Pitt, F. Zannad, and W. Remme, The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.341, issue.10, pp.709-726, 1999.
DOI : 10.1056/NEJM199909023411001

D. Julian, A. Camm, and G. Frangin, Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT, The Lancet, vol.349, issue.9053, pp.667-74, 1997.
DOI : 10.1016/S0140-6736(96)09145-3

J. Cairns, S. Connolly, R. Roberts, and M. Gent, Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT, The Lancet, vol.349, issue.9053, pp.675-82, 1997.
DOI : 10.1016/S0140-6736(96)08171-8

V. Fuster, L. Ryden, and D. Cannom, guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation), Eur Heart J, vol.27, pp.1979-2030, 2006.

S. Priori, E. Aliot, and C. Blomstrom-lundqvist, Task Force on Sudden Cardiac Death of the European Society of Cardiology, European Heart Journal, vol.22, issue.16, pp.3-18, 2002.
DOI : 10.1053/euhj.2001.2824

A. Kadish, A. Dyer, and J. Daubert, Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, New England Journal of Medicine, vol.350, issue.21, pp.2151-2159, 2004.
DOI : 10.1056/NEJMoa033088

S. Strickberger, J. Hummel, and T. Bartlett, Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia???AMIOVIRT, Journal of the American College of Cardiology, vol.41, issue.10, pp.1707-1719, 2003.
DOI : 10.1016/S0735-1097(03)00297-3

URL : https://doi.org/10.1016/s0735-1097(03)00297-3

A. Desai, J. Fang, W. Maisel, and K. Baughman, Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy, JAMA, vol.292, issue.23, pp.2874-2883, 2004.
DOI : 10.1001/jama.292.23.2874

D. Bansch, M. Antz, and S. Boczor, Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), 2002.

G. Bardy, K. Lee, and D. Mark, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, 2005.
DOI : 10.1016/j.accreview.2005.03.036

M. Bristow, L. Saxon, and J. Boehmer, Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, New England Journal of Medicine, vol.350, issue.21, pp.2140-50, 2004.
DOI : 10.1056/NEJMoa032423

E. Aliot, Indications du défibrillateur automatique implantable ventriculaire. Mise à jour de la version française, 2006.

S. Higgins, J. Hummel, and I. Niazi, Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias, Journal of the American College of Cardiology, vol.42, issue.8, pp.1454-1463, 2003.
DOI : 10.1016/S0735-1097(03)01042-8

W. Abraham, W. Fisher, and A. Smith, Cardiac Resynchronization in Chronic Heart Failure, New England Journal of Medicine, vol.346, issue.24, pp.1845-53, 2002.
DOI : 10.1056/NEJMoa013168

S. Goldstein and J. Guindo-soldevila, Sudden cardiac death, 1994.

P. Spector, Diagnosis and management of sudden cardiac death, Heart, vol.91, issue.3, pp.408-421, 2005.
DOI : 10.1136/hrt.2003.024026

M. Rubart and D. Zipes, Mechanisms of sudden cardiac death, Journal of Clinical Investigation, vol.115, issue.9, pp.2305-2320, 2005.
DOI : 10.1172/JCI26381

J. Leclercq, . Cp, P. Maison-blanche, M. Zimmermann, F. Chouty et al., Mise en évidence des mécanismes déterminants de la mort subite, Arch Mal Coeur, vol.79, pp.1024-1057, 1986.

B. Brembilla-perrot, J. De-bakker, F. Van-capelle, and M. Janse, Tachycardies ventriculaires Encyclopédie médicochirurgicale 1999 Slow conduction in the infarcted human heart. 'Zigzag' course of activation, Circulation, vol.6788, pp.915-941, 1993.

C. Loire, K. Mort-subite-von-olshausen, A. Schafer, H. Mehmel, F. Schwarz et al., Encyclopédie médicochirurgicale Ventricular arrhythmias in idiopathic dilated cardiomyopathy, Br Heart J, vol.6951, pp.195-201, 1984.

D. Bansch, M. Antz, and S. Boczor, Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT), Circulation, vol.105, issue.12, pp.1453-1461, 2002.
DOI : 10.1161/01.CIR.0000012350.99718.AD

W. Grimm, M. Christ, J. Bach, H. Muller, and B. Maisch, Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Results of the Marburg Cardiomyopathy Study, Circulation, vol.108, issue.23, pp.2883-91, 2003.
DOI : 10.1161/01.CIR.0000100721.52503.85

J. Teerlink, M. Jalaluddin, and S. Anderson, Ambulatory Ventricular Arrhythmias in Patients With Heart Failure Do Not Specifically Predict an Increased Risk of Sudden Death, Circulation, vol.101, issue.1, pp.40-46, 2000.
DOI : 10.1161/01.CIR.101.1.40

T. Meinertz, T. Hofmann, and W. Kasper, Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy, The American Journal of Cardiology, vol.53, issue.7, pp.902-909, 1984.
DOI : 10.1016/0002-9149(84)90522-8

M. Simson, Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction, Circulation, vol.64, issue.2, pp.235-277, 1981.
DOI : 10.1161/01.CIR.64.2.235

G. Zuanetti, J. Neilson, R. Latini, E. Santoro, A. Maggioni et al., Prognostic Significance of Heart Rate Variability in Post??Myocardial Infarction Patients in the Fibrinolytic Era: The GISSI-2 Results, Circulation, vol.94, issue.3, pp.432-438, 1996.
DOI : 10.1161/01.CIR.94.3.432

L. Fauchier, D. Babuty, P. Cosnay, and J. Fauchier, Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy, Journal of the American College of Cardiology, vol.33, issue.5, pp.1203-1210, 1999.
DOI : 10.1016/S0735-1097(99)00021-2

A. Gehi, R. Stein, L. Metz, and J. Gomes, Microvolt T-Wave Alternans for the Risk Stratification of Ventricular Tachyarrhythmic Events. A Meta-Analysis, ACC Current Journal Review, vol.14, issue.10, pp.75-82, 2005.
DOI : 10.1016/j.accreview.2005.09.078

M. Galinier, J. Vialette, and J. Fourcade, QT interval dispersion as a predictor of arrhythmic events in congestive heart failure Importance of aetiology, European Heart Journal, vol.19, issue.7, pp.1054-62, 1998.
DOI : 10.1053/euhj.1997.0865

M. Iacoviello, C. Forleo, and P. Guida, Ventricular Repolarization Dynamicity Provides Independent Prognostic Information Toward Major Arrhythmic Events in Patients With Idiopathic Dilated Cardiomyopathy, Journal of the American College of Cardiology, vol.50, issue.3, pp.225-256, 2007.
DOI : 10.1016/j.jacc.2007.02.071

B. Brembilla-perrot, J. Donetti, A. De-la-chaise, N. Sadoul, E. Aliot et al., Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy, American Heart Journal, vol.121, issue.4, pp.1124-1155, 1991.
DOI : 10.1016/0002-8703(91)90672-5

W. Stevenson, L. Stevenson, J. Weiss, and J. Tillisch, Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure, American Heart Journal, vol.116, issue.6, pp.1447-54, 1988.
DOI : 10.1016/0002-8703(88)90727-2

R. Damadian, Tumor Detection by Nuclear Magnetic Resonance, Science, vol.171, issue.3976, pp.1151-1154, 1971.
DOI : 10.1126/science.171.3976.1151

D. Pennell, U. Sechtem, and C. Higgins, Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report?, European Heart Journal, vol.25, issue.21, pp.1940-65, 2004.
DOI : 10.1016/j.ehj.2004.06.040

N. Bellenger, M. Burgess, and S. Ray, Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?, European Heart Journal, vol.21, issue.16, pp.1387-96, 2000.
DOI : 10.1053/euhj.2000.2011

A. Jacquier, B. Bartoli, and A. Flavian, Comment j???optimise la technique d???IRM ?? la recherche d???un rehaussement tardif???, Journal de Radiologie, vol.91, issue.5, pp.598-601
DOI : 10.1016/S0221-0363(10)70074-3

W. Roberts, R. Siegel, and B. Mcmanus, Idiopathic dilated Cardiomyopathy: Analysis of 152 necropsy patients, The American Journal of Cardiology, vol.60, issue.16, pp.1340-55, 1987.
DOI : 10.1016/0002-9149(87)90618-7

R. Kim, E. Chen, J. Lima, and R. Judd, Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused Infarction, Circulation, vol.94, issue.12, pp.3318-3344, 1996.
DOI : 10.1161/01.CIR.94.12.3318

T. Karamitsos, J. Francis, S. Myerson, J. Selvanayagam, S. Neubauer et al., The role of cardiovascular magnetic resonance imaging in heart failure Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death, J Am Coll Cardiol van der Burg AE Circulation, vol.54108, issue.89, pp.1407-241954, 2003.

J. Fenoglio, J. Pham, T. Harken, A. Horowitz, L. Josephson et al., Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates, Circulation, vol.68, issue.3, pp.518-551, 1983.
DOI : 10.1161/01.CIR.68.3.518

M. Spach, W. Miller, P. Dolber, J. Kootsey, J. Sommer et al., The functional role of structural complexities in the propagation of depolarization in the atrium of the dog. Cardiac conduction disturbances due to discontinuities of effective axial resistivity, Circulation Research, vol.50, issue.2, pp.175-91, 1982.
DOI : 10.1161/01.RES.50.2.175

M. Delmar, D. Michaels, T. Johnson, and J. Jalife, Effects of increasing intercellular resistance on transverse and longitudinal propagation in sheep epicardial muscle, Circulation Research, vol.60, issue.5, pp.780-785, 1987.
DOI : 10.1161/01.RES.60.5.780

S. Nazarian, D. Bluemke, and A. Lardo, Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy, Circulation, vol.112, issue.18, pp.2821-2826, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.549659

H. Hsia, D. Callans, and F. Marchlinski, Characterization of Endocardial Electrophysiological Substrate in Patients With Nonischemic Cardiomyopathy and Monomorphic Ventricular Tachycardia, Circulation, vol.108, issue.6, pp.704-714, 2003.
DOI : 10.1161/01.CIR.0000083725.72693.EA

F. Bogun, B. Desjardins, and E. Good, Delayed-Enhanced Magnetic Resonance Imaging in Nonischemic Cardiomyopathy, Journal of the American College of Cardiology, vol.53, issue.13, pp.1138-1183, 2009.
DOI : 10.1016/j.jacc.2008.11.052

H. Ashikaga, T. Sasano, and J. Dong, Magnetic Resonance Based Anatomical Analysis of Scar-Related Ventricular Tachycardia: Implications for Catheter Ablation, Circulation Research, vol.101, issue.9, pp.939-986, 2007.
DOI : 10.1161/CIRCRESAHA.107.158980

M. Yokokawa, H. Tada, and K. Koyama, The Characteristics and Distribution of the Scar Tissue Predict Ventricular Tachycardia in Patients with Advanced Heart Failure, Pacing and Clinical Electrophysiology, vol.38, issue.3, pp.314-336, 2009.
DOI : 10.1161/01.CIR.100.19.1992

M. Yokokawa, H. Tada, K. Koyama, S. Naito, S. Oshima et al., Nontransmural Scar Detected by Magnetic Resonance Imaging and Origin of Ventricular Tachycardia in Structural Heart Disease, Pacing and Clinical Electrophysiology, vol.18, issue.1, pp.52-58, 2009.
DOI : 10.1161/01.CIR.77.4.759

R. Assomull, S. Prasad, and J. Lyne, Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy, Journal of the American College of Cardiology, vol.48, issue.10, pp.1977-85, 2006.
DOI : 10.1016/j.jacc.2006.07.049

J. Mccrohon, J. Moon, and S. Prasad, Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance, Circulation, vol.108, issue.1, pp.54-63, 2003.
DOI : 10.1161/01.CIR.0000078641.19365.4C

A. Kono, K. Ishii, H. Kumagai, Y. Taniguchi, T. Kajiya et al., Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy?, Japanese Journal of Radiology, vol.109, issue.supplV, pp.355-61
DOI : 10.1536/ihj.32.1

S. Bohl, R. Wassmuth, and H. Abdel-aty, Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease, The International Journal of Cardiovascular Imaging, vol.15, issue.6, pp.597-607, 2008.
DOI : 10.1161/01.CIR.99.21.2750

J. Moon, W. Mckenna, J. Mccrohon, P. Elliott, G. Smith et al., Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance, Journal of the American College of Cardiology, vol.41, issue.9, pp.1561-1568, 2003.
DOI : 10.1016/S0735-1097(03)00189-X

URL : https://doi.org/10.1016/s0735-1097(03)00189-x

S. Silvera, E. Palangie, and J. Marmursztejn, Quelles pathologies myocardiques non isch??miques ont un rehaussement tardif et avec quelles caract??ristiques???, Journal de Radiologie, vol.91, issue.5, pp.609-623
DOI : 10.1016/S0221-0363(10)70076-7

K. Wu, R. Weiss, and D. Thiemann, Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy, Journal of the American College of Cardiology, vol.51, issue.25, pp.2414-2435, 2008.
DOI : 10.1016/j.jacc.2008.03.018

O. Cano, M. Hutchinson, and D. Lin, Electroanatomic Substrate and Ablation Outcome for Suspected Epicardial Ventricular Tachycardia in Left Ventricular Nonischemic Cardiomyopathy, Journal of the American College of Cardiology, vol.54, issue.9, pp.799-808, 2009.
DOI : 10.1016/j.jacc.2009.05.032

A. Codreanu, F. Odille, and E. Aliot, Electroanatomic Characterization of Post-Infarct Scars, Journal of the American College of Cardiology, vol.52, issue.10, pp.839-881, 2008.
DOI : 10.1016/j.jacc.2008.05.038

URL : https://hal.archives-ouvertes.fr/inserm-00616364

E. Choi, B. Choi, and S. Kim, Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy???, European Journal of Heart Failure, vol.42, issue.6
DOI : 10.1080/14017430701840317

K. Anderson, R. Walker, P. Urie, P. Ershler, R. Lux et al., Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy., Journal of Clinical Investigation, vol.92, issue.1, pp.122-162, 1993.
DOI : 10.1172/JCI116540